V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009109 | 280011774 | 1.81 | 68 | null | 2013-11-05 | 2013-11-10 | Cyclophosphamide + Vincristine | 02 | null | 280029991 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280009110 | 280011774 | 1.76 | 77 | Palliative (P) | 2015-10-26 | 2015-11-27 | Cyclophosphamide + Topotecan | Y | N | 280029991 | IDELALISIB |
| 280009111 | 280011774 | 1.75 | 65 | Palliative (P) | 2016-07-30 | 2016-08-09 | TRASTUZUMAB | null | null | 280029991 | VIDE |
| 280009112 | 280006333 | 1.66 | 61 | Palliative (P) | 2013-09-06 | 2014-04-09 | BEP 3 day | 02 | N | 280030002 | VIDE |
| 280009113 | 280009318 | 1.65 | 65.5 | Palliative (P) | null | 2017-12-08 | ECX | N | N | 280030003 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009114 | 280009318 | null | 52.3 | Palliative (P) | 2014-12-20 | 2014-12-27 | VINCRISTINE | N | null | 280030003 | ECX |
| 280009115 | 280009318 | 1.55 | null | null | 2017-01-14 | 2017-01-27 | Cyclophosphamide + Vincristine | null | null | 280030003 | CYCLOPHOSPHAMIDE + MTX |
| 280009116 | 280006339 | 1.62 | 78.6 | Adjuvant (A) | 2015-11-24 | 2015-12-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT | 2 | null | 280030011 | CISPLATIN + FLUOROURACIL + RT |
| 280009117 | 280006339 | 1.85 | 105.9 | Palliative (P) | 2016-02-19 | 2016-02-26 | Oxaliplatin + Raltitrexed | 2 | N | 280030011 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280009118 | 280006340 | 1.76 | null | null | 2018-06-04 | 2018-06-05 | CYCLOPHOSPHAMIDE + VINORELBINE | N | N | 280030024 | IMATINIB |
| 280009119 | 280006341 | 1.59 | 89.8 | Palliative (P) | 2015-10-03 | 2015-10-24 | Vemurafenib | N | N | 280030024 | VIA |
| 280009120 | 280006343 | 1.88 | 88.65 | null | null | 2017-02-22 | PEMBROLIZUMAB | null | null | 280030032 | NIVOLUMAB |
| 280009121 | 280006344 | 1.65 | 79.5 | Curative (C) | 2017-10-28 | 2018-02-27 | CYCLOPHOSPHAMIDE + ETOPOSIDE | null | null | 280030036 | ENZALUTAMIDE |
| 280009122 | 280006345 | 1.7 | 81.7 | Curative (C) | 2017-11-08 | 2017-11-14 | VIDE | N | N | 280030037 | VINCRISTINE |
| 280009123 | 280011776 | 1.65 | null | Curative (C) | 2015-03-05 | 2015-03-06 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280030045 | GEMCARBO |
| 280009124 | 280006349 | 1.76 | 80.95 | Not known (9) | null | 2014-06-08 | Dox + HD Mtx (post PAM) | 2 | N | 280030054 | VIDE |
| 280009125 | 280009324 | 1.7 | 68.9 | Palliative (P) | 2018-10-14 | 2018-10-22 | IVADo | N | N | 280030055 | BUSULFAN + MELPHALAN |
| 280009126 | 280006354 | 1.67 | 79 | Palliative (P) | 2016-12-19 | 2016-12-19 | CAPECITABINE + TEMOZOLOMIDE | 2 | N | 280030057 | PERTUZUMAB + TRASTUZUMAB |
| 280009127 | 280006356 | 1.7 | null | Palliative (P) | 2016-02-03 | 2016-04-24 | Capecitabine | 2 | N | 280030058 | BRENTUXIMAB |
| 280009128 | 280006357 | 1.82 | 84.9 | Curative (C) | 2017-04-26 | 2017-04-26 | Etoposide oral | N | N | 280030059 | IRINOTECAN + VINCRISTINE |
| 280009129 | 280009329 | null | 19.9 | null | 2017-05-11 | 2017-12-07 | VINCRISTINE | N | null | 280030062 | VIDE |
| 280009130 | 280010749 | 1.85 | 53 | null | 2017-06-09 | 2017-07-06 | CASPS TRIAL | Y | N | 280030067 | GEMCARBO |
| 280009131 | 280006361 | 1.72 | null | Palliative (P) | 2016-12-01 | 2016-12-01 | Bevacizumab | N | N | 280030068 | CAPECITABINE + GEMCITABINE |
| 280009132 | 280006363 | 1.75 | 89.2 | Palliative (P) | 2018-01-27 | 2018-02-02 | IPM | 02 | N | 280030068 | TIMELY TRIAL |
| 280009133 | 280011947 | null | 52.3 | Palliative (P) | 2018-04-21 | 2018-05-05 | Carbo F | N | Y | 280030071 | VINCRISTINE |
| 280009134 | 280006364 | null | 70.2 | null | 2015-10-29 | 2016-01-28 | Cisplatin + Fluorouracil + RT 5day | null | null | 280030073 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280009135 | 280009332 | null | 55 | null | 2017-04-06 | 2017-05-16 | Carbo F | Y | null | 280030074 | PAZOPANIB |
| 280009136 | 280009332 | 1.62 | 56.8 | null | 2013-08-26 | 2013-08-31 | Everolimus 10mg | N | N | 280030074 | CARBO + FLUOROURACIL |
| 280009137 | 280006368 | 1.82 | 68.4 | Adjuvant (A) | 2016-12-17 | 2017-01-02 | Capecitabine | N | N | 280030089 | DOCETAXEL |
| 280009138 | 280006369 | 1.6 | 68 | Neo-adjuvant (N) | 2014-10-07 | 2014-10-08 | OCTREOTIDE | N | null | 280030093 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009141 | 280006373 | 1.67 | null | Not known (9) | null | 2015-11-19 | Irinotecan | null | null | 280030100 | NAB-PACLITAXEL |
| 280009142 | 280006375 | null | 50.4 | Palliative (P) | 2016-04-13 | 2017-10-21 | Pemetrexed | 02 | N | 280030105 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009143 | 280009335 | 1.61 | 75 | Palliative (P) | 2017-06-21 | 2017-06-23 | ECX | 02 | N | 280030115 | CISPLATIN + FLUOROURACIL + RT |
| 280009144 | 280006377 | 1.98 | 69.7 | Palliative (P) | 2015-07-04 | 2015-07-04 | Docetaxel + Nintedanib | N | N | 280030118 | CARBOPLATIN + CETUXIMAB + FU |
| 280009145 | 280006378 | 1.57 | 55 | Palliative (P) | 2016-12-31 | 2017-01-02 | Capecitabine + Streptozocin | null | null | 280030120 | DOCETAXEL |
| 280009146 | 280006378 | 1.94 | null | Palliative (P) | 2018-03-10 | 2018-04-14 | Etoposide oral | null | N | 280030120 | IVADO |
| 280009147 | 280006379 | null | null | Curative (C) | 2018-10-11 | 2018-10-31 | VINCRISTINE | null | null | 280030124 | PEMBROLIZUMAB |
| 280009148 | 280010755 | 1.61 | 79.8 | Palliative (P) | 2013-08-15 | 2013-08-25 | CAPECITABINE + IRINOTECAN | 02 | N | 280030129 | CISPLATIN + FLUOROURACIL + RT |
| 280009149 | 280010755 | 1.65 | 93 | Palliative (P) | 2016-05-13 | 2016-05-16 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 280030129 | ECX |
| 280009150 | 280006382 | 1.81 | 108 | Disease modification (D) | 2016-11-24 | 2016-11-25 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280030134 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009151 | 280006382 | 1.78 | 64.8 | Palliative (P) | 2016-10-16 | 2016-10-31 | Ipilimumab | null | null | 280030134 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009152 | 280006382 | null | null | Palliative (P) | 2017-07-03 | 2017-09-29 | Cyclophosphamide + Vincristine | N | N | 280030134 | NIVOLUMAB |
| 280009153 | 280006383 | 0 | 40.5 | Palliative (P) | 2013-04-29 | 2013-05-23 | GemCarbo Days 1+8 | 02 | N | 280030140 | LIPOSOMAL DOXORUBICIN |
| 280009154 | 280009340 | 1.62 | null | Palliative (P) | 2017-10-01 | 2017-10-26 | Rituximab | 2 | N | 280030146 | TRASTUZUMAB |
| 280009155 | 280006384 | null | 68 | Palliative (P) | 2014-06-05 | 2014-06-05 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280030152 | DACTINOMYCIN + VINCRISTINE |
| 280009156 | 280006385 | null | 68 | Palliative (P) | 2016-07-29 | 2016-08-22 | NIVOLUMAB | null | null | 280030152 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009157 | 280006386 | null | 53.9 | Adjuvant (A) | 2014-07-27 | 2014-08-21 | GEMCITABINE + NAB PACLITAXEL | null | Y | 280030158 | CAPECITABINE + CISPLATIN |
| 280009158 | 280006387 | 1.57 | null | Disease modification (D) | 2013-04-11 | 2013-05-22 | Methotrexate High Dose (3g/m2) | N | N | 280030159 | VIDE |
| 280009159 | 280006387 | 1.8 | 40.2 | Palliative (P) | 2014-02-16 | 2015-03-29 | Erlotinib | 02 | N | 280030159 | IDELALISIB |
| 280009160 | 280006388 | null | 74 | Palliative (P) | null | 2015-12-10 | PEMBROLIZUMAB | null | null | 280030163 | CISPLATIN + FLUOROURACIL + RT |